Attitudes of patients to alternative medicine for cancer treatment

Asian Pacific Journal of Cancer Prevention

Volumn 6, Issue 2, 2005, Pages 125-129

  Chartterjee, Ashim Kumar ^a   Ganguly, Subir ^b   Pal, Sanjoy Kumar ^a,c   Chatterjee, Aradeep ^a   Mukhopadhyay, Gautam ^d   Bhakta, R S ^b  

^a New Horizon Center for Cancer Research and Treatment   (India)

^b MEDICAL COLLEGE AND HOSPITAL   (India)

^c SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^d Bengal Oncology Centre   (India)

Author keywords

Alternative cancer therapy; Awareness; Homeopathy; India

Indexed keywords

ADOLESCENT; ADULT; AGED; ALTERNATIVE MEDICINE; ARTICLE; ATTITUDE TO HEALTH; FEMALE; HUMAN; INDIA; MALE; MIDDLE AGED; NEOPLASM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COMPLEMENTARY THERAPIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INDIA; MALE; MIDDLE AGED; NEOPLASMS;

EID: 24944481762     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Cassileth BR, Chapman CC (1996). Alternative and complementary cancer therapies. Cancer, 77, 1026 - 34.
2. Chatterjee AK, Kundu PK, Bhakta RS, et al (1995). Nonconventional treatment of carcinoma: study of 52 cases. Bull Calcutta School Trop Med, 43, 17-20.
3. Chatterjee AK, Dutta SK, Bhakta RS, et al (1999). Use of Psorinum in the treatment of cancer. In: Verma A.K, (Ed.) Oral Cancer VI: 297 - 300. Macmillan India Ltd.
4. Chatterjee AK, Ganguly SK, Mukhopadhyay G, et al (2004). Nonconventional treatment of tobacco related cancer gradually gets right perspective through Psorinum therapy. In: Verma A.K, (Ed.) Tobacco Counters Health III. Macmillan India Ltd. p 159 - 166.
5. Chaturvedi P, Chaturvedi U, Sanyal B (2002). Alternative medicine and cancer patients in less developed countries, Lancet Oncol, 3, 10.
6. Coulehan J (1999). An alternative view: listening to patients. Lancet, 354, 1467- 8.
7. Crocetti E, Crotti N, Feltrin A, et al (1998). The use of complementary therapies by breast cancer patient attending conventional treatment. Eur J Cancer, 34, 324 - 8.
8. Ernst E (2001). Mistletoe for Cancer? Eur J Cancer, 37, 9-11.
9. Ernst E (2003). The current position of complementary/alternative medicine in cancer. Eur J Cancer, 39, 2273-7.
10. Esinberg DM, Kessler RC, Foster C, et al (1993). Unconventional medicine in the United States. N Engl J Med, 328, 246-52.
11. Gangopadhyay S, Mallik S (2003). Role of general practitioners in cancer management. J Indian Med Assoc, 101, 758-9.
12. Kaegi E (1998). Unconventional therapies for cancer: 1. Essiac. CMAJ, 158, 897-902.
13. Khuda-Bukhsh AR (1995). Alteration of X-ray effects by homeopathic drugs: a new approach in radio-protection. Perspective Cytol Genet, 8, 649-63.
14. Lerner IJ, Kennedy BJ (1992). The prevalence of questionable methods of cancer treatment in the United States. CA Cancer J Clin, 42, 181-91.
15. Mittra I (1999). Cancer control in countries with limited resources. In proceedings of XV Asia Pacific Cancer Conference. Held in Chennai, India, p10.
16. Morris KT, Johnson N, Homer L, Deb W (2000). A comparison of complementary therapy use between breast cancer patient and patients with other primary tumor sites. Am J Surg, 179, 407 -11.
17. Pal SK (2001). Use of new cancer drugs in India. Lancet Oncol, 2, 716.
18. Pal SK (2002a). Complementary and alternative medicine: An overview. Curr Sci, 82, 518-24.
19. Pal SK (2002b). Use of alternative cancer medicine in India. Lancet Oncol, 3, 394 - 5.
20. Pal SK (2002c). A retrospective study on cancer patient using alternative medicine: the Psorinum therapy. In proceedings of 1st International Symposium on Ayurveda, Yoga and Naturopathy. Held in Mahatma Gandhi Institute of Medical Sciences, Sevagram, from February 1 - 2, p 47.
21. Pal SK, Mittal B (2003). Importance of complementary and alternative cancer therapies in palliative oncology in India. J Alter Comp Med, 9, 811- 2.
22. Pal SK, Mittal B (2004). Improving cancer care in India: prospects and challenges. Asian Pacific J Cancer Prev, 5, 224-6.
23. Palani V, Senthilkumaran RK, Govindasamy S (1999). Biochemical evaluation of antitumor effect of Muthu Marunthu (a herbal formulation) on experimental fibrosarcoma in rats. J Ethnopharmacol, 65, 257-65.
24. Pathak S, Multani AS, Banerji P, Banerji P (2003). Ruta 6 selectively induces cell death in brain cancer cells but proliferation in normal peripheral blood lymphocytes: A novel treatment for human brain cancer. Int J Cancer, 23, 975-82.
25. Pellegrini R (1998). Di Bella's method of curing cancer is becoming popular in Italy. BMJ, 317, 352.
26. Sansom C, Mutuma G (2002). Kenya faces cancer challenges. Lancet Oncol, 3, 456 - 8.
27. Schraub S (2000). Unproven methods in cancer: a worldwide problem. Support Care Cancer, 8, 10 - 5.
28. Schwartsmann G, Ratain MJ, Cragg GM, et al (2002). Anticancer drug discovery and development through the world. J Clin Oncol, 20, 47s - 59s.
29. Sharma DC (2001). India allocates fund for 'composite treatment systems'. Lancet Oncol, 1,2, 330.
30. Shukla Y, Pal SK (2004). Complementary and alternative cancer therapies: past, present and the future scenario. Asian Pacific J Cancer Prev, 5, 3-14.
31. Sikora K (1997). Developing a global strategy for cancer. In: Proceedings of the XV Asia-Pasific Cancer Conference. Chennai, India, 7.
32. Smith M, Boon HS (1999). Counseling cancer patients about herbal medicine. Patient Educ Couns, 38, 109 - 20.
33. Sureshkumar K, Rajagopal M R (1996). Palliative care in Kerala. Problem at presentation in 440 patients with advanced cancer in a south Indian state. Palliative Med, 10, 293-8.
34. Thomas K, Sudhakar K (2000). Health-care inequalities an Indian perpestive. The Lancet Perspective, 356, s35.
35. Vicker AJ, Cassileth BR (2001). Unconventional therapies for cancer and cancer - related symptoms. Lancet Oncol, 2, 226-31.